Cargando…

Combined low vitamin D and K status amplifies mortality risk: a prospective study

OBJECTIVE: To explore the association of both plasma vitamin D and K concentrations with all-cause mortality, cardiovascular mortality, and cardiovascular events in the general population. METHODS: We studied 4742 participants of the Prevention of REnal and Vascular ENd-Stage Disease (PREVEND) Study...

Descripción completa

Detalles Bibliográficos
Autores principales: van Ballegooijen, Adriana J., Beulens, Joline W. J., Kieneker, Lyanne M., de Borst, Martin H., Gansevoort, Ron T., Kema, Ido P., Schurgers, Leon J., Vervloet, Marc G., Bakker, Stephan J. L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7987611/
https://www.ncbi.nlm.nih.gov/pubmed/32808059
http://dx.doi.org/10.1007/s00394-020-02352-8
_version_ 1783668647281033216
author van Ballegooijen, Adriana J.
Beulens, Joline W. J.
Kieneker, Lyanne M.
de Borst, Martin H.
Gansevoort, Ron T.
Kema, Ido P.
Schurgers, Leon J.
Vervloet, Marc G.
Bakker, Stephan J. L.
author_facet van Ballegooijen, Adriana J.
Beulens, Joline W. J.
Kieneker, Lyanne M.
de Borst, Martin H.
Gansevoort, Ron T.
Kema, Ido P.
Schurgers, Leon J.
Vervloet, Marc G.
Bakker, Stephan J. L.
author_sort van Ballegooijen, Adriana J.
collection PubMed
description OBJECTIVE: To explore the association of both plasma vitamin D and K concentrations with all-cause mortality, cardiovascular mortality, and cardiovascular events in the general population. METHODS: We studied 4742 participants of the Prevention of REnal and Vascular ENd-Stage Disease (PREVEND) Study. At baseline, vitamin D and K status was determined by measurement of 25-hydroxyvitamin D [25(OH)D] and dephosphorylated uncarboxylated matrix Gla protein (dp-ucMGP), respectively. Patients were categorized into: 25(OH)D < 50 or ≥ 50 nmol/L and dp-ucMGP < 361 or ≥ 361 pmol/L with 25(OH)D > 75 nmol/L and dp-ucMGP < 361 pmol/L as reference. Cause of death was coded according to International Classification of Diseases 9&10 codes from the 2001-2003 examination until date of death/event or censoring date (January 1st, 2017). RESULTS: Mean age was 52.6 ± 11.9 years and 2513 (53%) were female. During a median of 14.2 year follow-up, 620 participants died of which 142 were due to cardiovascular causes. Combined low vitamin D and K status was present in 970 participants (20%) and was associated with a greater risk of all-cause mortality compared to high vitamin D and high vitamin K status group (n = 1424) after adjusting for potential confounders: hazard ratio 1.46 (95% confidence intervals 1.12–1.90). We observed similar trends, albeit non-significant for cardiovascular mortality, and cardiovascular events: 1.42 (0.79–2.55), 1.28 (0.93–1.77), respectively. CONCLUSIONS: Combined low vitamin D and K status are associated with increased all-cause mortality risk and possibly with cardiovascular mortality and cardiovascular events compared with adequate vitamin D and K status. Future studies should investigate the effect of combined vitamin D and K supplementation on clinical outcomes. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00394-020-02352-8) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-7987611
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-79876112021-04-12 Combined low vitamin D and K status amplifies mortality risk: a prospective study van Ballegooijen, Adriana J. Beulens, Joline W. J. Kieneker, Lyanne M. de Borst, Martin H. Gansevoort, Ron T. Kema, Ido P. Schurgers, Leon J. Vervloet, Marc G. Bakker, Stephan J. L. Eur J Nutr Original Contribution OBJECTIVE: To explore the association of both plasma vitamin D and K concentrations with all-cause mortality, cardiovascular mortality, and cardiovascular events in the general population. METHODS: We studied 4742 participants of the Prevention of REnal and Vascular ENd-Stage Disease (PREVEND) Study. At baseline, vitamin D and K status was determined by measurement of 25-hydroxyvitamin D [25(OH)D] and dephosphorylated uncarboxylated matrix Gla protein (dp-ucMGP), respectively. Patients were categorized into: 25(OH)D < 50 or ≥ 50 nmol/L and dp-ucMGP < 361 or ≥ 361 pmol/L with 25(OH)D > 75 nmol/L and dp-ucMGP < 361 pmol/L as reference. Cause of death was coded according to International Classification of Diseases 9&10 codes from the 2001-2003 examination until date of death/event or censoring date (January 1st, 2017). RESULTS: Mean age was 52.6 ± 11.9 years and 2513 (53%) were female. During a median of 14.2 year follow-up, 620 participants died of which 142 were due to cardiovascular causes. Combined low vitamin D and K status was present in 970 participants (20%) and was associated with a greater risk of all-cause mortality compared to high vitamin D and high vitamin K status group (n = 1424) after adjusting for potential confounders: hazard ratio 1.46 (95% confidence intervals 1.12–1.90). We observed similar trends, albeit non-significant for cardiovascular mortality, and cardiovascular events: 1.42 (0.79–2.55), 1.28 (0.93–1.77), respectively. CONCLUSIONS: Combined low vitamin D and K status are associated with increased all-cause mortality risk and possibly with cardiovascular mortality and cardiovascular events compared with adequate vitamin D and K status. Future studies should investigate the effect of combined vitamin D and K supplementation on clinical outcomes. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00394-020-02352-8) contains supplementary material, which is available to authorized users. Springer Berlin Heidelberg 2020-08-17 2021 /pmc/articles/PMC7987611/ /pubmed/32808059 http://dx.doi.org/10.1007/s00394-020-02352-8 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Original Contribution
van Ballegooijen, Adriana J.
Beulens, Joline W. J.
Kieneker, Lyanne M.
de Borst, Martin H.
Gansevoort, Ron T.
Kema, Ido P.
Schurgers, Leon J.
Vervloet, Marc G.
Bakker, Stephan J. L.
Combined low vitamin D and K status amplifies mortality risk: a prospective study
title Combined low vitamin D and K status amplifies mortality risk: a prospective study
title_full Combined low vitamin D and K status amplifies mortality risk: a prospective study
title_fullStr Combined low vitamin D and K status amplifies mortality risk: a prospective study
title_full_unstemmed Combined low vitamin D and K status amplifies mortality risk: a prospective study
title_short Combined low vitamin D and K status amplifies mortality risk: a prospective study
title_sort combined low vitamin d and k status amplifies mortality risk: a prospective study
topic Original Contribution
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7987611/
https://www.ncbi.nlm.nih.gov/pubmed/32808059
http://dx.doi.org/10.1007/s00394-020-02352-8
work_keys_str_mv AT vanballegooijenadrianaj combinedlowvitamindandkstatusamplifiesmortalityriskaprospectivestudy
AT beulensjolinewj combinedlowvitamindandkstatusamplifiesmortalityriskaprospectivestudy
AT kienekerlyannem combinedlowvitamindandkstatusamplifiesmortalityriskaprospectivestudy
AT deborstmartinh combinedlowvitamindandkstatusamplifiesmortalityriskaprospectivestudy
AT gansevoortront combinedlowvitamindandkstatusamplifiesmortalityriskaprospectivestudy
AT kemaidop combinedlowvitamindandkstatusamplifiesmortalityriskaprospectivestudy
AT schurgersleonj combinedlowvitamindandkstatusamplifiesmortalityriskaprospectivestudy
AT vervloetmarcg combinedlowvitamindandkstatusamplifiesmortalityriskaprospectivestudy
AT bakkerstephanjl combinedlowvitamindandkstatusamplifiesmortalityriskaprospectivestudy